ICP blur
Health systems and provider groups can look alike until their operating model, priorities and buying constraints are examined.
HEALTHCARE & CLINICAL OPERATIONS TECHNOLOGY / $10,000+ B2B SALES
Still treating every healthcare account like a blank slate?
Scope reviewed account research around ICP fit, customer-return and ROI hypotheses, technical fit, timing, buyers, intent signals and positioning—before outreach is considered.
Business buyers onlyTechnical fit + timingSource-backed research
IS ALMA HUNTER FOR YOU?
Healthcare and clinical-operations technology sellers navigating complex enterprise buying conditions.
$10,000+ per typical order or contract. Not the price of Alma Hunter.THE COST OF THE WRONG CONVERSATION
Enterprise healthcare deals are rarely lost in a vacuum.
ROI without context
A generic savings claim misses the workflow owner, value location and measurement assumptions a credible hypothesis requires.
Complex buying paths
Clinical, operations, IT, security, procurement and finance stakeholders can shape the account before a seller sees the map.
STEP 02 / MAKE THE RESEARCH VISIBLE
A list becomes a case in three decisions.
The workflow changes for Healthcare & clinical operations technology, but every account moves through the same human-review logic.
- 01
Frame the account
Start with your offer, ICP and the account question that needs an answer.
- 02
Test the case
Separate value assumptions, delivery fit, evidence, buyer roles and timing.
- 03
Choose the next move
Pursue, validate, nurture or exclude with a visible rationale.
BEYOND LEAD GENERATION
Fewer blind spots.
A sharper next move.
Designed around your market—not another generic list.
Sharper account selection
Prioritize accounts against a defined ICP and rule out weak-fit targets with a documented rationale.
Defensible value hypothesis
Frame account-specific customer-return questions around the relevant workflow, constraints and value owners.
Better-informed positioning
Connect technical environment, public signals, likely stakeholders and timing context in a reviewed research brief.
WHAT WE HELP YOU TRACKThe numbers that make the work worth doing.Measurement goals—not guaranteed performance results.
Illustrative ICP-fit coverageIllustrative ROI hypotheses documentedIllustrative buyer-role coverageIllustrative technical-fit evidenceSTEP 04 / TEST THE CUSTOMER-RETURN HYPOTHESIS
Make the assumptions visible before you make the claim.
Use this lightweight sandbox to frame a question for Healthcare & clinical operations technology. It is not a quote, forecast, buyer result or performance promise.
- Baseline workflow volume and variation
- Current labor, delay or rework assumptions
- Implementation and integration constraints
- Value-owner priorities and measurement window
Illustrative ROI sandbox
ASSUMPTIONS ONLYRevenue / margin hypothesis$0
Cost-savings hypothesis$0
Time stays separate0 hours
These categories stay separate. Human review tests costs, measurement, feasibility and uncertainty before any return claim.
WHAT A BETTER FIT LOOKS LIKE
Research the business.
Then earn the conversation.
The end goal is a lead that fits your solution, has a supported a credible buyer return and technical fit, shows intent to buy, and falls within your timeframe. We find the buying team and position your value around that complete picture.
EXAMPLE BUYER ROLESVP clinical operationsChief information officerChief nursing informatics officerVP revenue cycle or finance
SIGNALS TO SCREEN AGAINST YOUR OFFERILLUSTRATIVE
EHR, interoperability or workflow change — research signal only.
Clinical-operations leadership or care initiative — research signal only.
Expansion, consolidation or service-line announcement — research signal only.
ILLUSTRATIVE EXAMPLE · NOT A CUSTOMER RESULT
Illustrative account brief: map a multi-site provider’s care workflow, likely technical dependencies, value owners, potential ROI logic and public timing context before deciding whether outreach is warranted.
Fit, buyer return, technical fit, intent and timing—all need evidence.
STEP 05 / MAP THE HUMAN DECISION
The account is not the buying group.
Relevant roles, signals and questions are research inputs—not proof that a buyer is ready.
1EHR, interoperability or workflow change — research signal only.2Clinical-operations leadership or care initiative — research signal only.3Expansion, consolidation or service-line announcement — research signal only.
ACCOUNTReviewed context
VP clinical operations
Chief information officer
Chief nursing informatics officer
VP revenue cycle or finance
Plausible decision roles to validate
ILLUSTRATIVE RESEARCH FLOW
See the logic before you send a brief.
This is a fictional sample—not live prospects, paid research or a performance promise.
THE DEMO WHEEL
Don’t just imagine it.
Take it for a spin.
YOUR NEXTOPPORTUNITY
Choose a suite, then a product.
One company. Clear capabilities.
One company. Clear capabilities.
PRESTIGE / PRODUCT DEMOSAMPLE
ALMA HUNTER / STEP 01
Screen ICP fit and the positive customer-return case.
Prescope a named account, target list or scoped CRM export against your exact ideal customer profile before outreach; CRM-wide volume is a managed scope, not an automatic run.
Audience$10,000+ B2B solution sellersOutcomeSupported buyer-return hypothesis
01 / 04
BEFORE YOU MAKE YOUR NEXT MOVE
The questions
worth asking.
Does Alma Hunter decide whether a healthcare provider will buy?+
No. It structures reviewed questions, evidence and unknowns; it does not promise a buyer decision or a sale.
What information do you need during onboarding?+
ICP first: ideal companies, buyer roles, size, revenue and exclusions. Then industries, verticals, your channels, customer success metrics with units, baselines and targets, and the KPIs your solution drives. Technical requirements, buying timeframe and research volume complete the brief.
How is Alma Hunter pricing determined?+
Pricing is determined by complexity and volume. We scope research depth, markets, custom qualification requirements and monthly account volume, then prepare a custom quote. The $10,000+ figure is your target sale value—not our price. The form does not generate a charge or fixed quote.
YOUR NEXT BIG-TICKET OPPORTUNITY
Start with your product.
Define your best-fit buyers.
Share your product page and examples of customers who already get value. Review the evidence, clarify your ICP and success metrics, then approve the brief we use to scope your research.
Your solution + your measurable valueBuyer return + technical fitBuying intent + your timeframe
Your next conversation starts with a business case.
Right-fit accounts. Supported value. The right people. A message that makes your specific advantage clear.